FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder)
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
360
|
194
|
1.000 |
definitive |
0.986 |
145 |
165
|
1996 |
2020 |
Fanconi Anemia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
394
|
173
|
0.700 |
strong |
0.978 |
135 |
64
|
1991 |
2020 |
leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
2111
|
144
|
0.600 |
strong |
1.000 |
1 |
|
2017 |
2017 |
Leukemia, Myelocytic, Acute
|
disease |
Neoplasms
|
Neoplastic Process
|
3111
|
6892
|
0.530 |
strong |
1.000 |
4 |
|
2002 |
2017 |
Estren-Dameshek Variant of Fanconi Pancytopenia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
1
|
|
0.500 |
definitive |
1.000 |
6 |
|
1996 |
2018 |
Estren-Dameshek Variant of Fanconi Anemia
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
1
|
|
0.500 |
definitive |
1.000 |
6 |
|
1996 |
2018 |
Pancytopenia
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
253
|
15
|
0.420 |
strong |
1.000 |
4 |
|
1996 |
2019 |
hearing impairment
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Otorhinolaryngologic Diseases
|
Disease or Syndrome
|
740
|
337
|
0.400 |
strong |
1.000 |
2 |
|
1996 |
2006 |
MYELODYSPLASTIC SYNDROME
|
group |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1033
|
95
|
0.400 |
strong |
1.000 |
1 |
|
2017 |
2017 |
Malignant neoplasm of urinary bladder
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2113
|
316
|
0.310 |
None |
1.000 |
2 |
|
2009 |
2013 |
Bladder Neoplasm
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
2130
|
281
|
0.310 |
None |
1.000 |
2 |
|
2009 |
2013 |
Acute monocytic leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
633
|
22
|
0.310 |
strong |
1.000 |
2 |
|
2003 |
2017 |
Bone marrow hypocellularity
|
phenotype |
|
Finding
|
64
|
5
|
0.300 |
strong |
1.000 |
2 |
|
1996 |
2006 |
Growth retardation, pre- and postnatal
|
phenotype |
|
Finding
|
3
|
|
0.300 |
strong |
1.000 |
2 |
|
1996 |
2006 |
Adenoid Cystic Carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
325
|
30
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Endogenous Hyperinsulinism
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
26
|
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
Miller Dieker syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome
|
182
|
9
|
0.300 |
strong |
1.000 |
1 |
|
2017 |
2017 |
Salivary Gland Neoplasms
|
group |
Neoplasms; Stomatognathic Diseases
|
Neoplastic Process
|
116
|
3
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Hyperinsulinism
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
620
|
64
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
Abnormality of radial ray
|
phenotype |
|
Finding
|
34
|
|
0.300 |
strong |
1.000 |
1 |
|
1996 |
1996 |
Compensatory Hyperinsulinemia
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
30
|
2
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
Malignant neoplasm of salivary gland
|
disease |
Neoplasms; Stomatognathic Diseases
|
Neoplastic Process
|
91
|
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Exogenous Hyperinsulinism
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
26
|
|
0.300 |
None |
1.000 |
1 |
|
2012 |
2012 |
Malignant Head and Neck Neoplasm
|
disease |
Neoplasms
|
Neoplastic Process
|
767
|
118
|
0.300 |
strong |
|
0 |
|
|
|
Adenocarcinoma of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
342
|
108
|
0.300 |
None |
|
0 |
|
|
|